Leukemia Clinical Trials in Florida

Showing 641-660 of 1,031 trials

Marrow Infiltrating Lymphocytes - Non-Small Cell Lung Cancer (MILs™ - NSCLC) Alone or in Combination With Nivolumab With or Without Tadalafil in Locally Advanced and Unresectable or Metastatic NSCLC

NCT04069936

The purpose of this study is to determine the safety and efficacy of MILs™ - NSCLC alone and in combination with nivolumab with or without tadalafil in subjects with locally advanced and unresectable or metastatic NSCLC who are refractory or relapsing to a PD-1 containing regimen.

Non Small Cell Lung CancerLung CancerLung Cancer Metastatic+5 more

WindMIL Therapeutics19 participantsStarted Oct 2019

Duarte, California, United States • Los Angeles, California, United States • Tampa, Florida, United States +7 more locations

COMPLETED49 miles

Interventional Validation of an MDS-Specific Measure of Quality of Life: Assessing the Responsiveness of the Quality of Life in Myelodysplasia Scale (QUALMS-1) to Different Hypomethylating Agent Regimens for Low and Intermediate Risk Disease

NCT02378701

The goal of this research study is to test a quality-of-life questionnaire called QUALMS-1 in patients with MDS. This is an investigational study. Up to 240 participants will be enrolled in this multicenter study. Up to 175 will take part at MD Anderson.

Leukemia

M.D. Anderson Cancer Center102 participantsStarted Feb 2015

Tampa, Florida, United States • Baltimore, Maryland, United States • Boston, Massachusetts, United States +3 more locations

PreviousPage 33 of 52Next

Marrow Infiltrating Lymphocytes - Non-Small Cell Lung Cancer (MILs™ - NSCLC) Alone or in Combination With Nivolumab With or Without Tadalafil in Locally Advanced and Unresectable or Metastatic NSCLC

Interventional Validation of an MDS-Specific Measure of Quality of Life: Assessing the Responsiveness of the Quality of Life in Myelodysplasia Scale (QUALMS-1) to Different Hypomethylating Agent Regimens for Low and Intermediate Risk Disease

Leukemia Trials in Other Cities

Study to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkins Lymphoma

Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic Regimens

Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)

Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy

CMF Bone Stimulation as Adjunct to Surgical Treatment of Ankle Fractures

Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors

Ublituximab in Combination With Ibrutinib Versus Ibrutinib Alone in Participants With Previously Treated High-Risk Chronic Lymphocytic Leukemia (CLL)

Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors

PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma

A Study of PLX2853 in Advanced Malignancies.

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

A Study Evaluating the Safety and Efficacy of Idasanutlin in Combination With Cytarabine and Daunorubicin in Patients Newly Diagnosed With Acute Myeloid Leukemia (AML) and the Safety and Efficacy of Idasanutlin in the Maintenance of First AML Complete Remission

Phase I/II Study of PDR001 in Patients With Advanced Malignancies

A Study of GDC-0853 in Patients With Resistant B-Cell Lymphoma or Chronic Lymphocytic Leukemia.

A Study of LY3023414 in Participants With Advanced Cancer

PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies

Other Conditions in Florida